Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Wyoming: The Complete Guide for Women, Families, and Survivors
For women across Wyoming, from the medical corridors of Cheyenne and Casper to the communities of Laramie, Sheridan, Gillette, and Rock Springs, the decision to undergo breast surgery is often one of the most personal and profound choices of their lives. Whether you are a breast cancer survivor in Wyoming navigating the complexities of post-mastectomy reconstruction, a BRCA1 or BRCA2 mutation carrier seeking a life-saving prophylactic procedure, or a woman pursuing aesthetic augmentation or revision in Wyoming’s private practices, you placed your trust in a medical device industry that promised safety and support. At The Manginello Law Firm, PLLC, operating as Attorney911, we have spent twenty-seven years witnessing the consequences when that trust is broken.
We represent Wyoming women who have been catastrophically injured by defective surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds used off-label in breast procedures. Our Managing Partner, Ralph Manginello, has been a licensed member of the State Bar of Texas (Bar Card Number 24007597) since November 6, 1998, and is admitted to the United States District Court for the Southern District of Texas. Together with Associate Attorney Lupe Peña, who brings a uniquely powerful background in insurance-defense litigation and conducts full client consultations in fluent Spanish, we provide Wyoming residents with the high-level legal firepower required to take on multi-billion-dollar medical device manufacturers.
If you are currently experiencing unexplained hardness, late-onset swelling, redness known as “red breast syndrome,” or have received a diagnosis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) or Squamous Cell Carcinoma (BIA-SCC) in Wyoming, you deserve the technical depth and clinical authority of a firm that understands the science of why these devices fail. Our team is currently prosecuting high-profile litigation like Bermudez v. Pi Kappa Phi, where we seek $10,000,000 in damages against thirteen defendants—a testament to our ability to handle complex, multi-party institutional liability. In Wyoming, where specialty reconstruction patients often travel to regional hubs in Colorado, Utah, or Montana, we offer the federal litigation experience necessary to ensure your case is heard regardless of where your surgery took place.
Understanding the Devices: Mesh, ADM, and Scaffolds in Wyoming Breast Surgery
The medical device landscape has shifted rapidly, and many Wyoming patients are unaware that the materials implanted during their surgery were never formally approved by the FDA for use in the breast. These products generally fall into three categories, each associated with distinct failure modes and immunological responses that we investigate for our Wyoming clients.
1. Acellular Dermal Matrix (ADM)
Acellular dermal matrix is a biological material derived from human cadaver skin (allograft) or animal tissue (xenograft, typically porcine or bovine). In Wyoming reconstruction procedures, surgeons use ADM to create a “pocket” for an implant or to reinforce the lower pole of the breast. Products like AlloDerm (Allergan/AbbVie), FlexHD (MTF Biologics), AlloMax (C.R. Bard/BD), and Strattice are ubiquitous. However, the FDA’s March 31, 2021 safety communication explicitly warned Wyoming healthcare providers about differing complication rates, naming FlexHD and AlloMax as having significantly higher rates of reoperation and infection.
2. Bioabsorbable and Resorbable Scaffolds
The “internal bra” technique often utilized in Wyoming mastopexy (breast lift) or reduction procedures utilizes synthetic scaffolds like GalaFLEX (Galatea Surgical/BD) or Phasix (C.R. Bard/BD). These are composed of poly-4-hydroxybutyrate (P4HB), a material designed to be absorbed by your body through hydrolysis. We are closely monitoring the litigation surrounding these devices in Wyoming, as P4HB hydrolysis kinetics can fail, leading to sterile inflammation or a failure to provide the structural support promised during the 18-to-24-month resorption window.
3. Synthetic Surgical Mesh
While less common in primary reconstruction, permanent synthetic meshes—often made of polypropylene—are sometimes used off-label in Wyoming under “internal bra” marketing. These synthetic materials were originally designed for abdominal hernia repair, not the delicate, vascularized environment of Wyoming women’s breast tissue. When these devices are used off-label, the manufacturer’s liability is often rooted in the failure to warn Wyoming surgeons about the specific risks of bacterial biofilm formation and chronic inflammatory responses.
The FDA Regulatory Failure: Why Wyoming Patients Weren’t Warned
The most critical fact most Wyoming patients don’t know is that none of these surgical mesh products have ever been cleared or approved by the FDA for use in breast surgery. Every woman in Wyoming who received GalaFLEX, Phasix, or AlloDerm in her breast had a device implanted through the 510(k) substantial-equivalence pathway.
Under 21 USC §360c and 21 CFR Part 807 Subpart E, the 510(k) pathway allows a manufacturer to bypass rigorous clinical safety trials by claiming their product is “substantially equivalent” to a “predicate” device already on the market. In Wyoming, we often see “predicate creep,” where a device like GalaFLEX cites a surgical suture as its predicate. A suture is not a breast scaffold. As the Supreme Court held in Medtronic v. Lohr (518 U.S. 470, 1996), 510(k) clearance is not a finding of safety and effectiveness; it is merely a comparative marketing clearance.
On November 9, 2023, the FDA issued a landmark letter to healthcare providers regarding BD mesh products, including Phasix and GalaFLEX. The agency stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” For our Wyoming clients, this 2023 letter is a foundational piece of evidence, as it underscores that the manufacturer’s off-label promotion bypassed the very safety barriers meant to protect Wyoming families.
The Clinical Cost: Complications Impacting Wyoming Women
When a medical device is defectively designed or inadequately sterilized, the biological cost is paid by the woman in Wyoming. Our firm, led by Ralph Manginello, examines medical records with microscopic detail to identify the specific failure modes associated with these devices.
- BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma): This is a CD30-positive, ALK-negative T-cell lymphoma that develops in the fluid or scar tissue (capsule) around textured implants. The Allergan BIOCELL voluntary recall of July 2019 was a response to data showing these implants were six times more likely to cause this malignancy. If you are in Wyoming and have developed a late-onset seroma (fluid collection) 7 to 10 years after surgery, you must seek immediate pathology to screen for this distinct lymphoma.
- BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma): A more recently identified epithelial tumor discovered in implant capsules. The FDA’s March 2023 update noted that this can occur in both smooth and textured implants, with a latency extending up to 42 years post-implantation.
- Red Breast Syndrome (RBS): This is a sterile, non-infectious inflammation specific to ADM. Peer-reviewed literature, including the work of Nguyen et al. (2019), points to an endotoxin-mediated mechanism. Bacterial endotoxins are not killed by irradiation or steam sterilization; they remain on products like FlexHD and can trigger a permanent red, painful rash for a Wyoming patient.
- Skin-Flap Necrosis and Reconstruction Failure: Studies show that ADM-assisted reconstruction more than doubles the risk of infection, with an odds ratio of 2.7 compared to non-ADM procedures. For a Wyoming woman who has just fought through chemotherapy, the loss of her reconstruction due to device-related infection at a center like Wyoming Medical Center in Casper or Cheyenne Regional Medical Center is a blow that warrants significant compensation.
Wyoming Statute of Limitations and the Discovery Rule
In Wyoming, the legal window to file a product liability claim is generally governed by Wyo. Stat. § 1-3-105, which provides a two-year statute of limitations for personal injury. However, for Wyoming women with latent injuries—where the lymphoma or the infection didn’t appear until years after the surgery—the “Discovery Rule” is our most important legal tool.
The clock typically does not start running until you knew, or reasonably should have known, that your injury was caused by the defective nature of the mesh or matrix. For many in Wyoming, the first moment they discovered this link was actually the FDA’s November 2023 letter. Ralph Manginello and Lupe Peña are experts at navigating these “statute of limitations” defenses, ensuring that Wyoming women are not barred from justice because a manufacturer concealed the truth for years.
Why Attorney911 is the Clear Choice for Wyoming Device Litigation
Choosing a firm is not just about finding a lawyer; it is about finding a team with a verified record of success in high-stakes litigation. Ralph Manginello carries an Avvo Rating of 8.2 (“Excellent”) and a Martindale-Hubbell Preeminent 5.0 of 5.0 rating. Our firm’s success is reflected in our Birdeye reviews, where we maintain a 4.9-star average across more than 470 reviews.
What sets us apart for Wyoming clients is our technical command and our bilingual advantage. Lupe Peña’s background in insurance defense allows us to anticipate the “learned intermediary” and “preemption” arguments the other side will use. If your family’s primary language is Spanish, Lupe conducts direct consultations without the need for an interpreter, ensuring that no detail of your Wyoming medical history is lost in translation.
We handle these cases on a contingency-fee basis. This means women in Wyoming pay nothing upfront and no hourly fees. We only get paid if we recover compensation for you. We are not a generalist personal injury firm; we are a trial-focused organization that understands the difference between a design defect and a manufacturing defect in the context of 21 CFR §803 Medical Device Reporting.
The Allergan BIOCELL MDL 2921 and the Path Forward for Wyoming
For those in Wyoming affected by textured implants, your case may be part of the consolidated multidistrict litigation (MDL 2921) currently before Judge Brian R. Martinotti in the District of New Jersey. The importance of the bellwether trial, currently scheduled for October 19, 2026, cannot be overstated. These trials set the settlement values for thousands of patients across the United States.
At Attorney911, we ensure Wyoming residents are positioned to benefit from these national proceedings. We don’t just file paperwork; we build a dossier for each Wyoming client that includes operative reports, device implant stickers (Unique Device Identifiers), and pathology slides. Whether you were treated at a specialty center serving Wyoming patients in Denver or Salt Lake City, or by a local plastic surgeon in Jackson Hole, our reach is national.
Taking Action Today: A Resource for Wyoming Families
If you or a loved one in Wyoming has experienced complications, do not wait for the manufacturer to contact you. They represent their shareholders; we represent you.
- Secure Your Operative Reports: Hospitals are required to maintain records of the devices they use. We help Wyoming clients track down these specific lot numbers.
- Consult a Specialist: If you have symptoms of BIA-ALCL or red breast syndrome in Wyoming, you need an independent second opinion.
- Contact Attorney911: Call 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation.
Ralph Manginello and Lupe Peña are ready to listen to your story. We have the credentials, the high-profile litigation experience (Bermudez v. Pi Kappa Phi), and the compassion required to handle your Wyoming case with the gravity it deserves. Your health and your rights are worth the fight.
Frequently Asked Questions for Wyoming Breast Mesh and ADM Patients
Is it too late to file a lawsuit in Wyoming if my surgery was years ago?
Not necessarily. Because of the Discovery Rule in Wyoming, the statute of limitations may not have begun running until you discovered the defect or the industry-wide safety warning. Each case requires a specific legal analysis.
Who is held liable—my surgeon or the manufacturer?
Our focus is primarily on the manufacturer for design defects and failure to warn. While medical malpractice may be a factor in some Wyoming cases, the central issue is often that the manufacturer provided misleading information to the surgeon.
What is the cost of a consultation?
There is no cost. We offer free case evaluations to every woman in Wyoming who believes she has been harmed by these devices.
Hablamos español. Contáctenos hoy mismo al 1-888-ATTY-911 para hablar directamente con Lupe Peña. Estamos aquí para proteger a las familias de Wyoming.
Attorney911: Aggressive Defense for the Injured in Wyoming. Dedicated to Justice. Determined to Win.
